ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
Steed1
|
24 |
11K |
8 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
24
|
11K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Change of Director's Interest Notice - J Basile
|
|
Steed1
|
11 |
5.3K |
10 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
11
|
5.3K
|
10
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
Steed1
|
24 |
11K |
1 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
24
|
11K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Steed1
|
1.1K |
567K |
27 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.1K
|
567K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
Steed1
|
160 |
81K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
81K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
Steed1
|
29 |
15K |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
29
|
15K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
21 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
14 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Steed1
|
1.1K |
567K |
60 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
1.1K
|
567K
|
60
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Steed1
|
1.1K |
567K |
39 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
1.1K
|
567K
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
13 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
18 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
Steed1
|
92 |
42K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
92
|
42K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
34 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
10K
|
4.8M
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Rollout
|
|
Steed1
|
128 |
64K |
20 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
128
|
64K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Steed1
|
1.1K |
567K |
30 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
1.1K
|
567K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Steed1
|
1.1K |
567K |
65 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
1.1K
|
567K
|
65
|
|
ASX - By Stock
|
NEU |
Re:
the game is ON
|
|
Steed1
|
123 |
62K |
7 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
123
|
62K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 8 November 2023
|
|
Steed1
|
22 |
12K |
53 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
22
|
12K
|
53
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
23 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
10K
|
4.8M
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Feedback
|
|
Steed1
|
47 |
22K |
4 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
47
|
22K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Feedback
|
|
Steed1
|
47 |
22K |
23 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
47
|
22K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Rollout
|
|
Steed1
|
128 |
64K |
11 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
128
|
64K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives US$40m milestone payment
|
|
Steed1
|
19 |
10K |
3 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
19
|
10K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
PHASE2 PRADER WILLI SYNDROME START !!!!
|
|
Steed1
|
36 |
25K |
1 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
36
|
25K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
PHASE2 PRADER WILLI SYNDROME START !!!!
|
|
Steed1
|
36 |
25K |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
36
|
25K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
11 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
10K
|
4.8M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Any doubts get out.
|
|
Steed1
|
32 |
12K |
1 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
32
|
12K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
10 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
10K
|
4.8M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
2 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
10K
|
4.8M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Steed1
|
1.1K |
567K |
23 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
1.1K
|
567K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
Steed1
|
221 |
97K |
12 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
221
|
97K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Shorting the sucker-rally
|
|
Steed1
|
342 |
119K |
28 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
342
|
119K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor Presentation, 14 March 2023
|
|
Steed1
|
145 |
70K |
5 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
145
|
70K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: FDA approves Daybue - the first treatment for Rett syndrome
|
|
Steed1
|
74 |
29K |
18 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
74
|
29K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
Steed1
|
163 |
81K |
18 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
163
|
81K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
Steed1
|
163 |
81K |
26 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
163
|
81K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
18 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
11 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
2 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
15 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
8 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
8 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
14 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
6 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
6 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
24 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
10K
|
4.8M
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Steed1
|
10K |
4.8M |
4 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
10K
|
4.8M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Trof Pricing - name your price
|
|
Steed1
|
21 |
10K |
3 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
21
|
10K
|
3
|
|